Structure-based drug design for new therapies for Leishmaniasis and Chagas disease (2025)
- Authors:
- Autor USP: SILBER, ARIEL MARIANO - ICB
- Unidade: ICB
- DOI: 10.1107/S2053273324099194
- Subjects: PARASITOLOGIA; PROTOZOA; ANTIPARASITÁRIOS; LEISHMANIA; AMINOÁCIDOS; DOENÇA DE CHAGAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Acta Crystallographica. Section A: Foundations and Advances
- ISSN: 2053-2733
- Volume/Número/Paginação/Ano: v. 80, res. e80, 2024
- Conference titles: European Crystallography Meeting
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
POHL, Ehmke et al. Structure-based drug design for new therapies for Leishmaniasis and Chagas disease. Acta Crystallographica. Section A: Foundations and Advances. Hoboken: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1107/S2053273324099194. Acesso em: 25 jan. 2026. , 2025 -
APA
Pohl, E., Silber, A. M., Pohl, S. F., & Sowerby, K. (2025). Structure-based drug design for new therapies for Leishmaniasis and Chagas disease. Acta Crystallographica. Section A: Foundations and Advances. Hoboken: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1107/S2053273324099194 -
NLM
Pohl E, Silber AM, Pohl SF, Sowerby K. Structure-based drug design for new therapies for Leishmaniasis and Chagas disease [Internet]. Acta Crystallographica. Section A: Foundations and Advances. 2025 ; 80[citado 2026 jan. 25 ] Available from: https://doi.org/10.1107/S2053273324099194 -
Vancouver
Pohl E, Silber AM, Pohl SF, Sowerby K. Structure-based drug design for new therapies for Leishmaniasis and Chagas disease [Internet]. Acta Crystallographica. Section A: Foundations and Advances. 2025 ; 80[citado 2026 jan. 25 ] Available from: https://doi.org/10.1107/S2053273324099194 - TcBDF2, a bromodomain factor, in Trypanosoma cruzi
- The Trypanosoma cruzi proteins TcCox10 and TcCox15 catalyze the formation of heme A in the yeast Saccharomyces cerevisiae
- A via prolina-glutamato de Trypanosoma cruzi: papéis biológicos e perspectivas terapêuticas
- Evaluation of the theraupetic perspectives of the L-Thiazolidine-4-carboxilic acid, A proline anologue, on mice infection by Trypanosoma cruzi
- Δ1-pyrroline-5-carboxilic acid (P5C) metabolism in Trypanosoma cruzi
- Cystathionine γ-lyase, an enzyme related to the reverse transsulfuration pathway, is functional in Leishmania spp
- Computational approaches for drug discovery against trypanosomatid-caused diseases
- Effect of 3,4-ethylenedioxy-extension of thiophene core on the DNA/RNA binding properties and biological activity of bisbenzimidazole amidines
- Actions of a proline analogue, L-thiazolidine-4- carboxylic acid (T4C), on Trypanosoma cruzi
- L-Glutamine uptake is developmentally regulated and is involved in metacyclogenesis in Trypanosoma cruzi
Informações sobre o DOI: 10.1107/S2053273324099194 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
